Increasing Participation in Cancer Clinical Trials
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Cancer
Both
Cancer
Trial Information
Increasing Participation in Cancer Clinical Trials
Inclusion Criteria:
- Patients who are potentially eligible for one of the designated clinical trials on
the basis of automated data from pathology reports and other databases
Exclusion Criteria:
- Patients who meet specific exclusion criteria for designated clinical trials
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Outcome Measure:
Proportion of patients eligible for designated clinical trials who actually enroll in one of these trials
Outcome Time Frame:
Up to three months after the index oncology visit
Safety Issue:
No
Principal Investigator
Carol P. Somkin, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Kaiser Permanente
Authority:
United States: Institutional Review Board
Study ID:
CN-04CSomk-02-B
NCT ID:
NCT00983866
Start Date:
September 2009
Completion Date:
July 2013
Related Keywords:
- Cancer
Name | Location |
|---|---|
| Kaiser Permanente Northern California | Oakland, California 94612 |
